Biodegradable microspheres. VII: Alterations in mouse liver morphology after intravenous administration of polyacryl

T Laakso1, P Edman, U Brunk

  • 1Department of Pharmaceutical Biochemistry, University of Uppsala, Sweden.

Insights

Polyacryl starch microparticles, used as drug carriers, caused reversible liver damage in mice. While spleen, lungs, and kidneys remained unaffected, liver tissue showed dose-dependent alterations and eventual normalization.

Area of Science:

  • Biomaterials Science
  • Toxicology
  • Drug Delivery Systems

Background:

  • Semisynthetic polyacryl starch microparticles are explored for drug delivery.
  • Understanding potential adverse effects of these microparticles is crucial for their clinical application.

Purpose of the Study:

  • To investigate the morphological alterations in mice following intravenous administration of polyacryl starch microparticles.
  • To assess the dose-dependency and reversibility of these observed changes.

Main Methods:

  • Intravenous administration of polyacryl starch microparticles to mice.
  • Histopathological examination of spleen, lungs, kidneys, and liver tissues.
  • Evaluation of dose-dependent and time-course effects on tissue morphology.

Main Results:

  • Spleen, lungs, and kidneys showed normal morphology post-administration.
  • Liver morphology exhibited dose-dependent, reversible alterations including hepatocyte vacuolization, necrosis, and granuloma formation.
  • Tissue regeneration was observed, with near-normalization within two weeks, though binucleated hepatocytes persisted.

Conclusions:

  • Polyacryl starch microparticles can induce reversible hepatic alterations in mice.
  • The observed liver changes suggest a potential toxicological profile that warrants further investigation for drug delivery applications.
  • Comparison with polyacrylamide microparticles may offer insights into material-specific toxic effects.